1. Home
  2. CFB vs ABCL Comparison

CFB vs ABCL Comparison

Compare CFB & ABCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CFB
  • ABCL
  • Stock Information
  • Founded
  • CFB 2007
  • ABCL 2012
  • Country
  • CFB United States
  • ABCL Canada
  • Employees
  • CFB N/A
  • ABCL N/A
  • Industry
  • CFB Major Banks
  • ABCL Biotechnology: Pharmaceutical Preparations
  • Sector
  • CFB Finance
  • ABCL Health Care
  • Exchange
  • CFB Nasdaq
  • ABCL Nasdaq
  • Market Cap
  • CFB 848.8M
  • ABCL 719.0M
  • IPO Year
  • CFB 2019
  • ABCL 2020
  • Fundamental
  • Price
  • CFB $17.13
  • ABCL $2.65
  • Analyst Decision
  • CFB Strong Buy
  • ABCL Buy
  • Analyst Count
  • CFB 5
  • ABCL 3
  • Target Price
  • CFB $18.80
  • ABCL $8.50
  • AVG Volume (30 Days)
  • CFB 260.1K
  • ABCL 2.6M
  • Earning Date
  • CFB 10-22-2024
  • ABCL 11-04-2024
  • Dividend Yield
  • CFB N/A
  • ABCL N/A
  • EPS Growth
  • CFB 19.65
  • ABCL N/A
  • EPS
  • CFB 1.47
  • ABCL N/A
  • Revenue
  • CFB $242,671,000.00
  • ABCL $32,962,000.00
  • Revenue This Year
  • CFB N/A
  • ABCL N/A
  • Revenue Next Year
  • CFB $9.11
  • ABCL $38.78
  • P/E Ratio
  • CFB $11.65
  • ABCL N/A
  • Revenue Growth
  • CFB 7.66
  • ABCL N/A
  • 52 Week Low
  • CFB $10.64
  • ABCL $2.34
  • 52 Week High
  • CFB $19.22
  • ABCL $6.06
  • Technical
  • Relative Strength Index (RSI)
  • CFB 55.10
  • ABCL 45.91
  • Support Level
  • CFB $15.27
  • ABCL $2.62
  • Resistance Level
  • CFB $17.92
  • ABCL $3.18
  • Average True Range (ATR)
  • CFB 0.50
  • ABCL 0.18
  • MACD
  • CFB 0.13
  • ABCL -0.01
  • Stochastic Oscillator
  • CFB 68.13
  • ABCL 22.06

About CFB CrossFirst Bankshares Inc.

CrossFirst Bankshares Inc is engaged in providing banking and financial services to businesses, business owners, professionals, and professional networks. The services offered by the company includes Checking accounts, Savings accounts, Personal Loans, International Banking, Business Loans, and Treasury services. The company generates revenue from interest income and fees on loans and interest earned from its marketable securities portfolio.

About ABCL AbCellera Biologics Inc.

AbCellera Biologics Inc is an antibody discovery and development engine that's specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and patients sooner. With the integrated AbCellera platform, the company's experts search a wide range of diverse antibodies to select the effective and developable leads fast and set partners up for enduring success. The company have extensive experience forging partnerships with emerging biotechs and pharmaceutical companies. AbCellera leverages proprietary hardware, software, and tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program.

Share on Social Networks: